Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2442706 | 0.87 | TSHR (0.52) | TSHRTHRBALDH1A1CYP3A4ATM | |
| SCHEMBL497290 | 0.86 | TSHR (0.59) | TSHRTHRBALDH1A1CYP3A4ATM | |
| SCHEMBL23494101 | 0.85 | TSHR (0.63) | TSHRTHRBALDH1A1CYP3A4ATM | |
| SCHEMBL481538 | 0.84 | TSHR (0.57) | TSHRTHRBALDH1A1CYP3A4ATM | |
| SCHEMBL7778317 | 0.84 | TSHR (0.50) | TSHRTHRBALDH1A1CYP3A4ATM | |
| SCHEMBL489030 | 0.83 | TSHR (0.60) | TSHRTHRBALDH1A1 | |
| SCHEMBL7779129 | 0.83 | TSHR (0.33) | TSHRCYP3A4ATMTDP1 | |
| SCHEMBL75001 | 0.82 | TSHR (0.63) | TSHRTHRBALDH1A1CYP3A4ATM | |
| SCHEMBL3974700 | 0.82 | TSHR (0.63) | TSHRTHRBALDH1A1CYP3A4ATM | |
| SCHEMBL22549211 | 0.81 | TSHR (0.58) | TSHRTHRBALDH1A1CYP3A4ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11820844-B2 | Charge-modified particles and methods of making the same | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-11-21 | — | — | US | claimed |
| US-20210009811-A1 | MODIFIED ALUMINUM NITRIDE PARTICLES AND METHODS OF MAKING THE SAME | 3M INNOVATIVE PROPERTIES COMPANY | 2021-01-14 | — | — | US | claimed |
| US-20210002137-A1 | CHARGE-MODIFIED PARTICLES AND METHODS OF MAKING THE SAME | 3M INNOVATIVE PROPERTIES COMPANY | 2021-01-07 | — | — | US | claimed |
| US-11820844-B2 | Charge-modified particles and methods of making the same | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-11-21 | — | — | US | disclosed |
| EP-3768794-B1 | CHARGE-MODIFIED PARTICLES AND METHODS OF MAKING THE SAME | 3M INNOVATIVE PROPERTIES CO (US) | 2021-04-28 | — | — | EP | disclosed |
| EP-3768655-A1 | MODIFIED ALUMINUM NITRIDE PARTICLES AND METHODS OF MAKING THE SAME | 3M Innovative Properties Company (US) | 2021-01-27 | — | — | EP | disclosed |
| EP-3768794-A2 | CHARGE-MODIFIED PARTICLES AND METHODS OF MAKING THE SAME | 3M Innovative Properties Company (US) | 2021-01-27 | — | — | EP | disclosed |
| US-20210009811-A1 | MODIFIED ALUMINUM NITRIDE PARTICLES AND METHODS OF MAKING THE SAME | 3M INNOVATIVE PROPERTIES COMPANY | 2021-01-14 | — | — | US | disclosed |
| US-20210002137-A1 | CHARGE-MODIFIED PARTICLES AND METHODS OF MAKING THE SAME | 3M INNOVATIVE PROPERTIES COMPANY | 2021-01-07 | — | — | US | disclosed |
| WO-2019180619-A1 | MODIFIED ALUMINUM NITRIDE PARTICLES AND METHODS OF MAKING THE SAME | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-09-26 | — | — | WO | disclosed |
| WO-2019180621-A2 | CHARGE-MODIFIED PARTICLES AND METHODS OF MAKING THE SAME | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-09-26 | — | — | WO | disclosed |
| EP-0909752-B1 | DI(METH)ACRYLATES | KYOWA YUKA KK (JP) | 2001-09-05 | — | — | EP | disclosed |
| EP-0909752-A1 | DI(METH)ACRYLATES | Kyowa Yuka Co., Ltd. (JP) | 1999-04-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210002137-A1 | CHARGE-MODIFIED PARTICLES AND METHODS OF MAKING THE SAME | PCTP, MBOAT1, CA13 | TSHR 1659/4885THRB 3742/4885ALDH1A1 3429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.